title: Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy.
abstract: In 80 patients with polycythaemia vera (PV) a total of 108 venous blood samples were obtained and analysed for EDTA-plasma erythropoietin (EPO) concentration. At the time of study 21 of the PV patients were newly diagnosed and had prior to blood sampling neither received phlebotomy treatment nor therapy with myelosuppressive agents; these subjects had a mean plasma EPO concentration of 0.5+/-0.9 IU/L. Thirty-seven patients treated with phlebotomy only had a mean plasma EPO concentration of 2.5+/-2.9 IU/L. The mean plasma EPO concentrations for 26 patients treated with hydroxyurea, 13 patients treated with radiophosphorous and 11 patients given a combination of myelosuppressive agents were 8.9+/-8.0, 10.9+/-12.6 and 7.2+/-7.4 IU/L, respectively. Untreated patients and patients on phlebotomy only had significantly lower values for plasma EPO than patients on therapy with myelosuppressive drugs. This finding persisted also after a correction for differences in haemoglobin levels had been introduced. Thereby, the present results would suggest a difference in the EPO feedback system in untreated and phlebotomised PV patients compared to PV patients treated with myelosuppressive agents.
authors.affiliation: Department of Medicine, Sahlgrenska University Hospital, University of Göteborg, Sweden.
authors.forename: B
authors.initials: B
authors.lastname: Andréasson
authors.forename: J
authors.initials: J
authors.lastname: Carneskog
authors.forename: G
authors.initials: G
authors.lastname: Lindstedt
authors.forename: P A
authors.initials: PA
authors.lastname: Lundberg
authors.forename: B
authors.initials: B
authors.lastname: Swolin
authors.forename: H
authors.initials: H
authors.lastname: Wadenvik
authors.forename: J
authors.initials: J
authors.lastname: Kutti
mesh_terms: D000328:Adult; D000368:Aged; D002066:Busulfan / Q000627:therapeutic use; D004921:Erythropoietin / Q000097:blood*; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D018962:Phlebotomy; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000097:blood* / Q000628:therapy*
chemical_list: D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D010761:Phosphorus Radioisotopes; D004921:Erythropoietin; D002066:Busulfan; D006918:Hydroxyurea